Renata Ferrarotto, John M. Kaczmar, David R. Spigel, Christine H. Chung, Dan Paul Zandberg, Irene Braña, Caroline Even, Kevin Joseph Harrington, Lisa F. L. Licitra, Bhumsuk Keam, Danny Rischin, Melvin L.K. Chua, Ralf Reiners, Rita Dalal, Glenn J. Hanna. "A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo in combination with pembrolizumab for first-line treatment of HPV-negative, PD-L1–positive, recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): FORTIFI-HN01.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps6129